Alpha Teknova (TKNO) Operating Expenses (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Operating Expenses came in at $8.1 million in Q1 2026, up 1.39% year-on-year from $8.0 million in Q1 2025, and up 2.92% on a QoQ basis from $7.9 million in Q4 2025.
Alpha Teknova (TKNO) Operating Expenses (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Operating Expenses data on file, last reported at $8.1 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 1.39% year-over-year to $8.1 million in Q1 2026; TTM through Mar 2026 was $30.5 million, a 2.01% decrease from a year earlier, with the FY2025 full-year figure at $30.4 million, down 8.87% from the prior year.
- Operating Expenses for Q1 2026 stood at $8.1 million, up from $7.9 million in the prior quarter.
- Over the last five years, Operating Expenses for TKNO reached as high as $27.7 million in Q3 2022 and fell as low as $7.2 million in Q3 2025.
- Historically, Operating Expenses has averaged $10.9 million across 5 years, with a median of $10.2 million in 2024.
- Across the five-year window, Operating Expenses surged 240.13% in 2022 and slumped 63.09% in 2023, its largest moves.
- Year by year, Operating Expenses stood at $16.3 million in 2022, then dropped by 25.41% to $12.2 million in 2023, then tumbled by 36.39% to $7.8 million in 2024, then advanced by 1.25% to $7.9 million in 2025, then rose by 2.92% to $8.1 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $8.1 million in Q1 2026, $7.9 million in Q4 2025, and $7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.08 Mn |
| Dec 31, 2025 | 7.85 Mn |
| Sep 30, 2025 | 7.22 Mn |
| Jun 30, 2025 | 7.37 Mn |
| Mar 31, 2025 | 7.97 Mn |
| Dec 31, 2024 | 7.76 Mn |
| Sep 30, 2024 | 7.52 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 10.20 Mn |
| Dec 31, 2023 | 12.19 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 11.37 Mn |
| Dec 31, 2022 | 16.35 Mn |
| Sep 30, 2022 | 27.72 Mn |
| Jun 30, 2022 | 11.87 Mn |
| Mar 31, 2022 | 11.19 Mn |
| Dec 31, 2021 | 9.75 Mn |
| Sep 30, 2021 | 8.15 Mn |
| Jun 30, 2021 | 5.88 Mn |